Oxytocin Modulates Nociception as an Agonist of Pain-Sensing TRPV1
Yelena Nersesyan,
Lusine Demirkhanyan,
Deny Cabezas-Bratesco,
Victoria Oakes,
Ricardo Kusuda,
Tyler Dawson,
Xiaohui Sun,
Chike Cao,
Alejandro Martin Cohen,
Bharath Chelluboina,
Krishna Kumar Veeravalli,
Katharina Zimmermann,
Carmen Domene,
Sebastian Brauchi,
Eleonora Zakharian
Affiliations
Yelena Nersesyan
Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, 1 Illini Drive, Peoria, IL 61605, USA
Lusine Demirkhanyan
Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, 1 Illini Drive, Peoria, IL 61605, USA
Deny Cabezas-Bratesco
Instituto de Fisiologia, Facultad de Medicina, Universidad Austral de Chile, and Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Valdivia 5110566, Chile
Victoria Oakes
Department of Chemistry, King’s College London, Britannia House, 7 Trinity Street, London, SE1 1DB, UK
Ricardo Kusuda
Department of Anesthesia, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes 3900, 14049-900 Ribeirão Preto, Brazil
Tyler Dawson
Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, 1 Illini Drive, Peoria, IL 61605, USA
Xiaohui Sun
Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, 1 Illini Drive, Peoria, IL 61605, USA; College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215123, China
Chike Cao
Ion Channel Research Unit, Duke University Medical Center, Durham, NC 27710, USA
Alejandro Martin Cohen
Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University, 5850 College Street, P.O. Box 15000, Halifax, NS B3H 4R2, Canada
Bharath Chelluboina
Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, 1 Illini Drive, Peoria, IL 61605, USA
Krishna Kumar Veeravalli
Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, 1 Illini Drive, Peoria, IL 61605, USA
Katharina Zimmermann
Department of Anesthesia, Friedrich-Alexander University Erlangen-Nürnberg, Krankenhausstrasse 12, 91054 Erlangen, Germany
Carmen Domene
Department of Chemistry, King’s College London, Britannia House, 7 Trinity Street, London, SE1 1DB, UK; Chemistry Research Laboratory, Mansfield Road, University of Oxford, Oxford, OX1 3TA, UK
Sebastian Brauchi
Instituto de Fisiologia, Facultad de Medicina, Universidad Austral de Chile, and Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Valdivia 5110566, Chile
Eleonora Zakharian
Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, 1 Illini Drive, Peoria, IL 61605, USA; Corresponding author
Summary: Oxytocin is a hormone with various actions. Oxytocin-containing parvocellular neurons project to the brainstem and spinal cord. Oxytocin release from these neurons suppresses nociception of inflammatory pain, the molecular mechanism of which remains unclear. Here, we report that the noxious stimulus receptor TRPV1 is an ionotropic oxytocin receptor. Oxytocin elicits TRPV1 activity in native and heterologous expression systems, regardless of the presence of the classical oxytocin receptor. In TRPV1 knockout mice, DRG neurons exhibit reduced oxytocin sensitivity relative to controls, and oxytocin injections significantly attenuate capsaicin-induced nociception in in vivo experiments. Furthermore, oxytocin potentiates TRPV1 in planar lipid bilayers, supporting a direct agonistic action. Molecular modeling and simulation experiments provide insight into oxytocin-TRPV1 interactions, which resemble DkTx. Together, our findings suggest the existence of endogenous regulatory pathways that modulate nociception via direct action of oxytocin on TRPV1, implying its analgesic effect via channel desensitization. : Oxytocin is known to suppress painful stimuli of inflammatory origin. Nersesyan et al. now find that oxytocin attenuates pain via the pain-sensing receptor TRPV1. Keywords: transient receptor potential vanilloid 1, TRPV1 ion channel, oxytocin, nociception, oxytocin receptor, planar lipid bilayers, molecular dynamics simulations, MD simulations